Affiliation:
1. Department of Chemical Engineering University of Massachusetts Lowell Lowell Massachusetts USA
2. Department of Pharmaceutical Science University of Massachusetts Lowell Lowell Massachusetts USA
Abstract
AbstractA majority of the biotherapeutics industry today relies on the manufacturing of monoclonal antibodies from Chinese hamster ovary (CHO) cells, yet challenges remain with maintaining consistent product quality from high‐producing cell lines. Previous studies report the impact of individual trace metal supplemental on CHO cells, and thus, the combinatorial effects of these metals could be leveraged to improve bioprocesses further. A three‐level factorial experimental design was performed in fed‐batch shake flasks to evaluate the impact of time wise addition of individual or combined trace metals (zinc and copper) on CHO cell culture performance. Correlations among each factor (experimental parameters) and response variables (changes in cell culture performance) were examined based on their significance and goodness of fit to a partial least square's regression model. The model indicated that zinc concentration and time of addition counter‐influence peak viable cell density and antibody production. Meanwhile, early copper supplementation influenced late‐stage ROS activity in a dose‐dependent manner likely by alleviating cellular oxidative stress. Regression coefficients indicated that combined metal addition had less significant impact on titer and specific productivity compared to zinc addition alone, although titer increased the most under combined metal addition. Glycan analysis showed that combined metal addition reduced galactosylation to a greater extent than single metals when supplemented during the early growth phase. A validation experiment was performed to confirm the validity of the regression model by testing an optimized setpoint of metal supplement time and concentration to improve protein productivity.
Funder
Advanced Mammalian Biomanufacturing Innovation Center
National Institute for Innovation in Manufacturing Biopharmaceuticals
Reference33 articles.
1. Human cell lines for biopharmaceutical manufacturing: history, status, and future perspectives
2. Handbook of Carbohydrate-Modifying Biocatalysts
3. Monoclonal antibody therapy market size, share & COVID‐19 impact analysis, by type (human mAb, humanized mAb, chimeric mAb, and murine mAb), by application (cancer, autoimmune diseases, and others), by distribution channel (hospital pharmacy retails pharmacy, and online pharmacy), and regional forecast, 2012‐2018;Aleem A;Fortune Business Insights,2021
4. Tailoring recombinant protein quality by rational media design
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献